SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-03-15 16:31
Tx date 2022-03-15 		$ADYA
ADYA INC. 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,145
+13,000 vol
$0.165 each 		35,000
Filed 2022-03-15 16:30
Tx date 2022-03-15 		$ADYA
ADYA INC. 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$160.00
+1,000 vol
$0.16 each 		22,000
Filed 2022-03-15 16:29
Tx date 2022-03-15 		$ADYA
ADYA INC. 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$77.50
+500 vol
$0.155 each 		21,000
Filed 2022-03-15 16:29
Tx date 2022-03-15 		$ADYA
ADYA INC. 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$465.00
+3,000 vol
$0.155 each 		20,500
Filed 2022-03-15 16:27
Tx date 2022-03-11 		$ADYA
ADYA INC. 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,625
+17,500 vol
$0.15 each 		17,500
Filed 2020-12-18 07:08
Tx date 2020-12-16 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,569,291 vol 		4,484,463
Filed 2020-11-27 13:38
Tx date 2020-11-26 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$78,133
+3,125,327 vol
$0.025 each 		4,551,727
Filed 2020-04-02 17:42
Tx date 2020-03-30 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$104,645
+2,315,172 vol
$0.0452 each 		2,915,172
Filed 2020-03-11 11:53
Tx date 2020-03-11 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-25,000 vol 		600,000
Filed 2019-12-13 14:18
Tx date 2019-03-10 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-25,000 vol 		625,000
Filed 2019-12-13 14:16
Tx date 2018-04-26 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-25,000 vol 		450,000
Filed 2019-12-13 14:15
Tx date 2017-03-12 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-25,000 vol 		375,000
Filed 2019-12-13 14:14
Tx date 2016-07-16 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-25,000 vol 		200,000
Filed 2019-11-27 15:57
Tx date 2019-11-19 		$ADYA
ADYA INC. 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-29
Tx date 2019-03-29 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$500,000
+2,564,103 vol
$0.195 each 		4,558,730
Filed 2019-03-07
Tx date 2019-03-06 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$26,000
+200,000 vol
$0.13 each 		725,000
Filed 2018-12-26
Tx date 2018-12-24 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$49,463
+429,000 vol
$0.1153 each 		1,994,627
Filed 2018-12-11
Tx date 2018-12-11 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$4,117
+30,500 vol
$0.135 each 		1,565,627
Filed 2018-12-11
Tx date 2018-12-10 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$2,632
+19,500 vol
$0.135 each 		1,535,127
Filed 2018-12-07
Tx date 2018-12-07 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$43,200
+320,000 vol
$0.135 each 		1,515,627
Filed 2018-09-11
Tx date 2018-09-10 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$22,560
+94,000 vol
$0.24 each 		1,195,627
Filed 2018-09-11
Tx date 2018-09-07 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$5,760
+24,000 vol
$0.24 each 		1,101,627
Filed 2018-08-22
Tx date 2018-08-21 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$10,080
+42,000 vol
$0.24 each 		1,077,627
Filed 2018-08-20
Tx date 2018-08-17 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$9,450
+35,000 vol
$0.27 each 		1,035,627
Filed 2018-03-26
Tx date 2018-03-23 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		525,000
Filed 2018-03-26
Tx date 2018-03-22 		$ASP
Acerus Pharmaceuticals Corporation 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$99,184
+374,000 vol
$0.2652 each 		1,000,627
Filed 2017-12-01
Tx date 2017-11-24 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,200
+16,000 vol
$0.20 each 		1,231,500
Filed 2017-12-01
Tx date 2017-11-24 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$29,202
+157,000 vol
$0.186 each 		1,213,500
Filed 2017-12-01
Tx date 2017-11-24 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$390.00
+2,000 vol
$0.195 each 		1,215,500
Filed 2017-12-01
Tx date 2017-11-23 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$20,760
+120,000 vol
$0.173 each 		1,056,500
Filed 2017-12-01
Tx date 2017-11-27 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$40,929
+194,900 vol
$0.21 each 		1,426,400
Filed 2017-12-01
Tx date 2017-11-23 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,845
+28,500 vol
$0.17 each 		936,500
Filed 2017-09-01
Tx date 2017-08-28 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$30,245
+263,000 vol
$0.115 each 		908,000
Filed 2017-03-24
Tx date 2017-03-20 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,782
+15,500 vol
$0.115 each 		512,127
Filed 2017-03-24
Tx date 2017-03-20 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$11,040
+96,000 vol
$0.115 each 		608,127
Filed 2017-03-24
Tx date 2017-03-20 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$2,127
+18,500 vol
$0.115 each 		626,627
Filed 2017-03-13
Tx date 2017-03-10 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		425,000
Filed 2016-08-22
Tx date 2016-08-19 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$49,000
+350,000 vol
$0.14 each 		645,000
Filed 2016-03-31
Tx date 2016-03-28 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,690
+13,000 vol
$0.13 each 		269,627
Filed 2016-03-31
Tx date 2016-03-28 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$31,780
+227,000 vol
$0.14 each 		496,627
Filed 2016-03-31
Tx date 2016-03-28 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Holder: 8197288 Canada Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$1,200
+10,000 vol
$0.12 each 		256,627
Filed 2016-03-08
Tx date 2016-03-04 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		225,000
Filed 2015-12-29
Tx date 2015-12-29 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,200
+28,000 vol
$0.15 each 		295,000
Filed 2015-12-29
Tx date 2015-12-29 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,739
+12,000 vol
$0.145 each 		267,000
Filed 2015-12-29
Tx date 2015-12-22 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$11,900
+85,000 vol
$0.14 each 		255,000
Filed 2015-12-29
Tx date 2015-12-22 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$16,675
+115,000 vol
$0.145 each 		170,000
Filed 2015-09-24
Tx date 2015-09-23 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,000
+20,000 vol
$0.40 each 		55,000
Filed 2015-09-24
Tx date 2015-09-21 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,905
+7,000 vol
$0.415 each 		35,000
Filed 2015-09-24
Tx date 2015-09-21 		$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) 		Gregory, Stephen Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,260
+3,000 vol
$0.42 each 		28,000